NCT00034619已完成2 期
A Phase 2 Trial of ALIMTA (LY231514, Pemetrexed) Plus Oxaliplatin Administered Every 21 Days for First-Line Treatment of Patients With Advanced Colorectal Cancer.
适应症
相关药物
试验速览
- 阶段
- 2 期
- 状态
- 已完成
- 试验地点
- 22
研究概览
简要总结
The purpose of this study is to assess the antitumor activity of ALIMTA plus Oxaliplatin combination therapy in patients with previously untreated advanced colorectal cancer
研究设计
- 研究类型
- Interventional
- 主要目的
- Treatment
入排标准
- 年龄范围
- 18 Years 至 —（Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •Diagnosis of primary cancer of the colon or rectum
- •Must have measurable disease
- •Must be able to comply with study procedure
排除标准
- •Prior chemotherapy for advanced disease
- •Pregnancy or lactation
- •Candidates for surgical resection of one or more metastatic foci
- •Second primary cancer
- •Inability to take folic acid or vitamin B12
研究者
研究点 (22)
Loading locations...
相似试验
终止
2 期
Pemetrexed &Oxaliplatin in Patients w Recurrent NSCLCa After Failure to Platinum Based Adjuvant ChemLung CancerNCT00612677H. Lee Moffitt Cancer Center and Research Institute1
已完成
2 期
Phase II Study of Oxaliplatine-Paclitaxel in Patients With Metastatic Germ Cell Tumor Refractory to CisplatinNeoplasms, Germ Cell and EmbryonalNCT00611962Sanofi27
已完成
1 期
Pemetrexed and Oxaliplatin in Treating Patients With Metastatic Solid Tumors or LymphomaSolid TumorLymphomaNCT00470405Vanderbilt-Ingram Cancer Center25
已完成
2 期
Study of Pemetrexed in Mesothelioma and Lung Cancer Patients With Fluid Around the Lungs or AbdomenMesotheliomaLung NeoplasmsNon-small Cell Lung CancerNCT00316225Eli Lilly and Company31
进行中（未招募）
不适用
A Phase 1 and 2 Clinical Trial of ALIMTA (Pemetrexed) in Combination with Carboplatin in Patients with Recurrent Ovarian or Primary Peritoneal Cancer(Sweden will participate in Phase 2 of this trial, only)platinum sensitive recurrent ovarian or primary peritoneal cancerMedDRA version: 8.1Level: LLTClassification code 10033130Term: Ovarian cancer NOSEUCTR2004-002782-20-SEEli Lilly and Company Limited85